Birdwatch Note
2024-02-27 15:24:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Der Artikel bezieht keine kritische Einordnung der von Dr Kleinschnitz getätigten Aussagen mit ein. Diese stellen in medizinischen Fachkreisen eine Mindermeinung dar. Weitere Studien belegen Kontraindikation von Aktivierungstherapie sowie einen Nachweis von Biomarkern https://www.nature.com/articles/s41579-022-00846-2 https://www.sciencemediacenter.de/alle-angebote/research-in-context/details/news/biomarker-zur-bestimmung-von-long-covid/ https://www.pharmazeutische-zeitung.de/biomarker-fuer-long-covid-gefunden-144914/ https://www.cam.ac.uk/research/news/long-covid-linked-to-persistently-high-levels-of-inflammatory-protein-a-potential-biomarker-and
Written by 05C7EA0FAA9877CCBC0D4277B45C6D3BAB877E58B5DD84DB922D0D324BAEBBB7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1762441310940614858
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1762498852039397520
- noteId - 1762498852039397520
- participantId -
- noteAuthorParticipantId - 05C7EA0FAA9877CCBC0D4277B45C6D3BAB877E58B5DD84DB922D0D324BAEBBB7 Participant Details
- createdAtMillis - 1709047446628
- tweetId - 1762441310940614858
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Der Artikel bezieht keine kritische Einordnung der von Dr Kleinschnitz getätigten Aussagen mit ein. Diese stellen in medizinischen Fachkreisen eine Mindermeinung dar. Weitere Studien belegen Kontraindikation von Aktivierungstherapie sowie einen Nachweis von Biomarkern https://www.nature.com/articles/s41579-022-00846-2 https://www.sciencemediacenter.de/alle-angebote/research-in-context/details/news/biomarker-zur-bestimmung-von-long-covid/ https://www.pharmazeutische-zeitung.de/biomarker-fuer-long-covid-gefunden-144914/ https://www.cam.ac.uk/research/news/long-covid-linked-to-persistently-high-levels-of-inflammatory-protein-a-potential-biomarker-and
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-02-27 15:24:06 UTC (1709047446628) |
2024-02-28 00:19:09 UTC (1709079549924) |
CURRENTLY_RATED_HELPFUL | 2024-03-07 12:28:42 UTC (1709814522945) |
NEEDS_MORE_RATINGS | 2024-02-28 00:19:09 UTC (1709079549924) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-02-28 05:22:00 -0600 | Rating Details | |
| 2024-02-28 04:01:42 -0600 | Rating Details | |
| 2024-02-28 01:24:00 -0600 | Rating Details | |
| 2024-02-28 00:58:11 -0600 | Rating Details | |
| 2024-02-28 00:26:29 -0600 | Rating Details | |
| 2024-02-28 00:24:00 -0600 | Rating Details | |
| 2024-02-27 21:09:26 -0600 | Rating Details | |
| 2024-02-27 17:12:07 -0600 | Rating Details | |
| 2024-02-27 15:15:38 -0600 | Rating Details | |
| 2024-02-27 15:12:01 -0600 | Rating Details | |
| 2024-02-27 14:51:27 -0600 | Rating Details | |
| 2024-02-27 14:47:18 -0600 | Rating Details | |
| 2024-02-27 13:59:27 -0600 | Rating Details | |
| 2024-02-27 13:44:47 -0600 | Rating Details | |
| 2024-02-27 13:40:36 -0600 | Rating Details | |
| 2024-02-27 13:01:50 -0600 | Rating Details | |
| 2024-02-27 12:11:36 -0600 | Rating Details | |
| 2024-02-28 16:44:58 -0600 | Rating Details | |
| 2024-02-28 01:39:45 -0600 | Rating Details | |
| 2024-02-28 00:05:33 -0600 | Rating Details | |
| 2024-02-27 16:45:15 -0600 | Rating Details | |
| 2024-02-27 16:14:01 -0600 | Rating Details | |
| 2024-02-27 15:48:02 -0600 | Rating Details | |
| 2024-02-27 15:46:05 -0600 | Rating Details | |
| 2024-02-27 15:35:56 -0600 | Rating Details | |
| 2024-02-27 15:10:17 -0600 | Rating Details | |
| 2024-02-27 14:10:08 -0600 | Rating Details | |
| 2024-02-27 13:37:30 -0600 | Rating Details | |
| 2024-02-27 10:28:47 -0600 | Rating Details | |
| 2024-02-27 10:26:25 -0600 | Rating Details | |
| 2024-02-28 23:58:45 -0600 | Rating Details | |
| 2024-02-28 14:04:59 -0600 | Rating Details | |
| 2024-02-28 07:01:47 -0600 | Rating Details | |
| 2024-02-28 01:40:58 -0600 | Rating Details | |
| 2024-02-28 00:31:59 -0600 | Rating Details | |
| 2024-02-27 20:01:40 -0600 | Rating Details | |
| 2024-02-27 15:33:14 -0600 | Rating Details | |
| 2024-02-27 15:14:12 -0600 | Rating Details | |
| 2024-02-27 15:07:11 -0600 | Rating Details | |
| 2024-02-27 14:11:32 -0600 | Rating Details | |
| 2024-02-27 14:07:54 -0600 | Rating Details | |
| 2024-02-27 10:22:58 -0600 | Rating Details | |
| 2024-02-27 09:34:03 -0600 | Rating Details | |
| 2024-03-17 07:57:58 -0500 | Rating Details | |
| 2024-06-03 09:14:23 -0500 | Rating Details |